Florence S. Gilson Named Vice President of Quality Assurance/Quality Control for Solvay Pharmaceuticals
Marietta, Ga. – December 13, 2006 – Florence S. Gilson has been promoted to vice president of quality assurance/quality control, the Americas, for Solvay Pharmaceuticals. In this role, Gilson assumes responsibility for quality assurance and quality control activities for the company in the United States, Canada, Mexico and Brazil.
A 16-year veteran of Solvay Pharmaceuticals, Inc., Gilson began her career with the company in the regulatory affairs department where she performed various compliance-related functions. Over the next decade, she held positions of increasing responsibility and most recently was director of quality assurance compliance and training and senior compliance officer. In her new role, Gilson also will serve as a member of the U.S. Pharmaceutical Leadership Team.
Prior to joining Solvay Pharmaceuticals, Gilson was manager of quality control for Interbake Foods, Inc. in Richmond, Va. She began her career in quality assurance at Bio/dynamics in East Millstone, N.J.
“Flo has been a key part of our quality organization and an integral part of the company’s quality assurance and control programs for many years,” said Laurence J. Downey, M.D., president and chief executive officer of Solvay Pharmaceuticals, Inc. “Her expertise in pharmaceutical quality control and compliance matters makes her an ideal leader for this organization and we congratulate her on this promotion.”
Gilson graduated from Allegheny College in Meadville, Pa., with a B.S. degree in biology. She is a member of the Society of Quality Assurance, Drug Information Association and the Food and Drug Law Institute.
About Solvay Pharmaceuticals
Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit www.solvaypharmaceuticals-us.com.
Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, specialized markets and men’s and women’s health. Its 2005 sales were EUR 2.3 billion and it employs approximately 10,000 people worldwide. For more information, visit www.solvaypharmaceuticals.com.
SOLVAY is an international chemical and pharmaceutical group with headquarters in Brussels. It employs some 30,000 people in 50 countries. In 2005 its consolidated sales amounted to EUR 8.6 billion, generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. SOLVAY (Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the Euronext stock exchange in Brussels. Details are available at www.solvay.com.
